Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

EMED Notes New Major Shareholder

Thu, 31st Jul 2014 11:19

LONDON (Alliance News) - EMED Mining Thursday said Trafigura Beheer BV, through its subsidiary Urion holdings Ltd, has acquired 202.0 million shares in the company at a value of 9 pence per share.

The minerals development and exploration company, which has assets in Spain and Slovakia, said that Trafigura now holds roughly 18.18% of the company with a total 228.2 million shares.

Trafigura is a Dutch commodity trading company which focuses on base metals and energy.

EMED said that Trafigura has let it know that it acquired the shares for investment purposes only and that changing market conditions may force it to change its ownership.

EMED also said that Trafigura has no role in management of EMED and has not appointed any nominees to the Board of Directors of EMED.

The company also said that one of its shareholders Resource Capital Fund IV LP has disposed of its entire 167.0 million shares in the company, which represented roughly 13.3% of the issued share capital.

EMED shares were up 3.9% to 7.40 pence on Thursday.

By Tom McIvor; tommcivor@alliancenews.com; @TomMcIvor1

Copyright 2014 Alliance News Limited. All Rights Reserved.


Shares in this article

Related News

TRADING UPDATES: Smiths gets Euros sticker boost; Hotel Chocolat grows
13 Jul 2021

TRADING UPDATES: Smiths gets Euros sticker boost; Hotel Chocolat grows

TRADING UPDATES: Smiths gets Euros sticker boost; Hotel Chocolat grows

Astrazeneca + 11 more shares
DIRECTOR DEALINGS: Berkeley Group non-exec buys GBP660,000 in shares
6 Jul 2021

DIRECTOR DEALINGS: Berkeley Group non-exec buys GBP660,000 in shares

DIRECTOR DEALINGS: Berkeley Group non-exec buys GBP660,000 in shares

Berkeley Group + 2 more shares
TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook
24 Jun 2021

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

Bezant Resources PLC + 20 more shares